Approaches to assessing the provider experience with clinical pharmacogenomic information: a scoping review.
Genet Med
; 23(9): 1589-1603, 2021 09.
Article
em En
| MEDLINE
| ID: mdl-33927377
ABSTRACT
PURPOSE:
Barriers to the implementation of pharmacogenomics in clinical practice have been thoroughly discussed over the past decade.METHODS:
The objective of this scoping review was to characterize the peer-reviewed literature surrounding the experiences and actions of prescribers, pharmacists, or genetic counselors when using pharmacogenomic information in real-world or hypothetical research settings.RESULTS:
A total of 33 studies were included in the scoping review. The majority of studies were conducted in the United States (70%), used quantitative or mixed methods (79%) with physician or pharmacist respondents (100%). The qualitative content analysis revealed five major methodological approaches hypothetical clinical case scenarios, real-world studies evaluating prescriber response to recommendations or alerts, cross-sectional quantitative surveys, cross-sectional qualitative surveys/interviews, and a quasi-experimental real-world study.CONCLUSION:
The findings of this scoping review can guide further research on the factors needed to successfully integrate pharmacogenomics into clinical care.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Farmacogenética
/
Médicos
Tipo de estudo:
Guideline
/
Observational_studies
/
Prevalence_studies
/
Qualitative_research
/
Risk_factors_studies
/
Systematic_reviews
Limite:
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article